Gut Microbiome Signal Appeared Before Parkinson’s Symptoms in GBA1 Carriers TL;DR: In people carrying a genetic risk factor for Parkinson’s but not yet symptomatic, about 25% of their gut microbiome signature already looked intermediate between healthy controls and diagnosed patients — and the shift tracked with early warning signs like sleep disruption and smell loss. …
Low-Level Drinking Was Not Invisible to the Aging Cortex TL;DR: Even drinking within low-risk guidelines was linked to lower cortical blood flow and thinner cortex when lifetime exposure met advancing age. Key Findings All participants stayed under 60 drinks per month: The cohort excluded alcohol use disorder and focused on healthy non-smoking adults reporting low-level …
EPA Rewired Brain Vessels After Repetitive Brain Injury TL;DR: Fish-oil-derived EPA looked less like a simple neuroprotective supplement and more like a lipid signal that changed brain-vessel repair after repetitive mild traumatic brain injury. Key Findings EPA accumulated before injury: In a fish-oil diet model, eicosapentaenoic acid built up in the brain at baseline rather …
Mediterranean Diet Linked Mitochondrial Microproteins TL;DR: Mediterranean diet adherence tracked with higher mitochondrial microproteins Humanin and SHMOOSE in older adults, pointing to a possible mitochondrial route for healthy-aging benefits. Key Findings Higher adherence tracked with SHMOOSE: Patients with stronger Mediterranean diet adherence showed higher circulating SHMOOSE levels. Humanin moved with diet and Nox2: Humanin was …
Dopamine Disruption May Start Alzheimer’s Memory Failure TL;DR: In an Alzheimer’s mouse model, early memory failure tracked a broken dopamine signal into the lateral entorhinal cortex, and both optogenetic dopamine reactivation and L-DOPA partially restored learning. Key Findings Early learning slipped: Young APP knock-in mice reached 78.6% correct trials in the final learning block, compared …
C4A Broke Away From C1Q in First-Episode Psychosis TL;DR: In cerebrospinal fluid from people with first-episode psychosis, the usual positive relationship between C4A and C1Q disappeared, while C4A’s broader immune-network pattern shifted sharply in a way C4B did not. Key Findings C4A-C1Q coupling broke in psychosis: The study compared 113 patients with first-episode psychosis against …
Alzheimer’s Treatment Needs More Than Amyloid TL;DR: A 2026 review in Science China Life Sciences argues that amyloid-beta antibodies such as lecanemab and donanemab are important progress, but Alzheimer’s treatment cannot stop at amyloid. The disease also involves tau tangles, genetics, aging biology, immune changes, vascular and metabolic health, and systemic conditions that shape whether …
Alpha-Synuclein Testing Could Clarify Dementia Diagnosis TL;DR: In 398 memory-clinic patients, alpha-synuclein seed testing identified Lewy body dementia with 95% sensitivity and revealed hidden synuclein positivity in 15.8% of Alzheimer’s disease cases. Key Findings Seed testing separated Lewy body dementia: The ALZAN cohort recruited memory-clinic patients from Montpellier, Nimes, and Perpignan between November 2022 and …
Hormone Therapy Linked to 44% Improvement in Menopause Mood Symptoms TL;DR: Menopausal hormone therapy tracked with a 44.59% improvement in mood-symptom scores after about 107 days, across both peri- and postmenopausal women — and the gains were broadly similar regardless of which hormonal regimen was used. Key Findings 44.59% improvement in mood symptoms: After initiating …
Semaglutide Linked to 42% Fewer Psychiatric Hospital Episodes TL;DR: In Swedish registry data covering nearly 100,000 people with depression or anxiety, psychiatric hospital visits and sickness absence were 42% lower during semaglutide treatment periods — with comparable reductions in depression, anxiety, and substance-use outcomes. Key Findings 42% lower psychiatric care during semaglutide periods: Psychiatric hospital …
